In this peeriodical, I comment on recent articles in the realm of Immunology. Take-home message and Importance are included for a clear and concise literature review
Editors Nicolas Tremblay Maude Boisvert
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors (2018)
Thomas Duhen, Rebekka Duhen, Ryan Montler, Jake Moses, Tarsem Moudgil, Noel F. de Miranda, Cheri P. Goodall, Tiffany C. Blair, Bernard A. Fox, Jason E. McDermott, Shu-Ching Chang, Gary Grunkemeier, Rom Leidner, Richard Bryan Bell, Andrew D. Weinberg
PubMed: 30006565 DOI: 10.1038/s41467-018-05072-0
Take home message In this article, Duhen et al. identifies a new subset of CD8+ cells that are recruited and maintained within the tumor micro-environment. Using flow-cytometry and microarrays, they show that these tumor-infiltrating CD8 T cells have an exhaustion signature and have a Tissue-resident memory T (Trm) phenotype. Interestingly, these cells are also tumour-reactive and have a TCR repertoire capable of recognizing and killing autologous tumous cells. Of clinical relevance, they show that an increase frequency of these cells, at the time of operation, is correlated with a decrease risk of death in patients with head and neck squamous cell carcinoma. Importance The paper provides novel insight into the biology of tumor-infiltrating CD8+ T cells that could be harness for increase our fundamental knowledge of cancer biology, but that is also interesting for the development of novel therapeutic/diagnostic tools.